novartis gets eu approval for pandemic flu vaccine swiss drug maker novartis ag said it won european union approval for its focetria pandemic influenza vaccine the approval means a vaccine could be produced that is adapted to a particular strain of influenza if a pandemic is declared by the world health organization because the vaccine needs to be adapted to a particular strain it is unsuitable for stockpiling reuters 
